Anzeige
Mehr »
Samstag, 07.03.2026 - Börsentäglich über 12.000 News
Unglaubliche News: Nasdaq-Smallcap - Diese KI erkennt, was kein Labor sehen kann!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HJ9 | ISIN: CA8475771033 | Ticker-Symbol: SD4
Frankfurt
06.03.26 | 08:01
0,810 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SPECTRAL MEDICAL INC Chart 1 Jahr
5-Tage-Chart
SPECTRAL MEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,8150,85510:01

Aktuelle News zur SPECTRAL MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoThis analyst loves Spectral Medical2
26.02.Spectral Medical Inc: Spectral delays seeking premarket OK for PMX to mid-May3
26.02.Stocks in Play: Spectral Medical Inc-
26.02.Spectral Medical Inc.: Spectral Medical Provides Update on PMA Submission Timing for PMX-20R74TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
SPECTRAL MEDICAL Aktie jetzt für 0€ handeln
07.11.25Spectral Medical GAAP EPS of -$0.11, revenue of $0.6M2
07.11.25Spectral Medical Inc.: Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update213PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on Wednesday, December 10, 2025 TORONTO, Nov. 07, 2025 (GLOBE...
► Artikel lesen
30.09.25Spectral Medical Inc: Spectral Medical files base shelf prospectus2
29.09.25Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF1
16.09.25Spectral Medical Inc: Spectral study defines deadliest septic shock group1
16.09.25Spectral Medical Inc.: Spectral Medical Announces Publication of EDEN Observational Study8
25.08.25Spectral Medical Inc.: Spectral Medical Receives US$3 Million From Vantive376TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
13.08.25XFRA SD4: WIEDERAUFNAHME/RESUMPTION384FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
13.08.25XFRA SD4: AUSSETZUNG/SUSPENSION233DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSPECTRAL MEDICAL...
► Artikel lesen
12.08.25Spectral Medical Inc.: Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock238Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary...
► Artikel lesen
08.08.25Spectral Medical Inc.: Spectral Medical Announces Second Quarter and Provides Corporate Update254Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic...
► Artikel lesen
06.06.25Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders196TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
09.05.25Spectral Medical Inc.: Spectral Medical Announces First Quarter and Provides Corporate Update282Tigris Trial Enrollment completedTopline results expected to be released in August 2025Entered into an up to US$10 million Promissory Note with Vantive to Fund Spectral to PMX commercialization ...
► Artikel lesen
07.05.25Spectral Medical Inc.: Spectral Medical Announces Non-Dilutive Financing of Up to $10 Million with Vantive351• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to...
► Artikel lesen
16.04.25Spectral Medical Inc.: Spectral Medical Completes Tigris Trial Enrollment283157 patients enrolledTopline results expected to be released in August 2025Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc....
► Artikel lesen
27.03.25Spectral Medical Inc.: Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update381TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1